TherapeuticsMD (TXMD) Gross Profit Growth (1y) (2012 - 2023)
TherapeuticsMD (TXMD) Gross Profit Growth (1y) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.91 Bn | 88.04 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.17 Bn | 1.97 Bn | 5.06% |
| 3 | Zoetis | 32.54 Bn | 30.60 Bn | 1.62 Bn | 2.59% |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | -18.38% |
| 5 | United Therapeutics | 23.05 Bn | 20.89 Bn | 648.10 Mn | -7.66% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | -0.34% |
| 8 | Neurocrine Biosciences | 17.82 Bn | 16.50 Bn | 800.70 Mn | 42.12% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 14.77% |
| 10 | TherapeuticsMD | 280,418.39 | -8.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -99.27% |
| Mar 31, 2023 | -97.13% |
| Dec 31, 2022 | 391.83% |
| Mar 31, 2022 | -4.65% |
| Dec 31, 2021 | -17.98% |
| Sep 30, 2021 | 25.28% |
| Jun 30, 2021 | 199.46% |
| Mar 31, 2021 | 59.18% |
| Dec 31, 2020 | 30.52% |
| Sep 30, 2020 | -27.89% |
| Jun 30, 2020 | 30.46% |
| Mar 31, 2020 | 199.50% |
| Dec 31, 2019 | 214.64% |
| Sep 30, 2019 | 702.70% |
| Jun 30, 2019 | 45.97% |
| Mar 31, 2019 | 1.43% |
| Dec 31, 2018 | 17.25% |
| Sep 30, 2018 | -25.34% |
| Jun 30, 2018 | -7.26% |
| Mar 31, 2018 | -5.62% |